Figure 1.
Distribution of cefiderocol MICs for all isolates and clinical category according to investigational CLSI breakpoints. I, intermediate; R, resistant; S, susceptible.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.